The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $2.79, a high ...

OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate ...

OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) shares saw an uptick in trading volume on Wednesday following insider buying activity. 3,744,040 shares were traded during trading, a decline of 8% ...

Board of Directors has authorized an increase of $100M to the Company’s existing common stock repurchase program, bringing ...

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common ...

The aggregate repurchase authorization program now totals $200 million, which the firm will fund with cash and cash equivalents.

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism surrounding the stock is backed by RAYALDEE’s performance and ...

OPK's growth is fueled by Rayaldee's success and promising pipeline progress. However, margin pressure and overdependence on its lead product are concerning.